Sigyn Therapeutics's total assets for Q2 2025 were $51.76K, a decrease of -78.81% from the previous quarter. SIGY total liabilities were $5.49M for the fiscal quarter, a 5.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.